Updated from 12:16 p.m. EST
With the merger between
, the attempted takeover of
by Roche, rumors of a potential buyout of
, and the overall positive action in
recently, many analysts and investors believe that 2009 will be a positive year for the biotech industry as a whole.
Important events in the biotech space include
binary data announcement on its key drug Provenge in early April and Genentech's update on various uses for Avastin late April.
Taking a step back from the more commonly covered biotech names, let's look at
, formally called Orthologic, ticker symbol OLGC.
How would you like to buy a $1.14 stock for less than 40 cents?
To read more,
Stockpickr is a wholly owned subsidiary of TheStreet.com.